Straumann (OTCMKTS:SAUHY) Stock Price Down 3.6% – Should You Sell?

Straumann Holding AG (OTCMKTS:SAUHY) dropped 3.6% during trading on Friday . The company traded as low as $11.52 and last traded at $11.52. 15,830 shares traded hands during trading, a decline of 88% from the average daily volume of 133,481 shares. The stock had previously closed at $11.95.

Wall Street Analysts Forecast Growth

SAUHY has been the subject of several research reports. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research report on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft lowered Straumann from a “buy” rating to a “hold” rating in a report on Friday. BMO Capital Markets assumed coverage on Straumann in a research report on Wednesday, July 8th. They set an “outperform” rating on the stock. Barclays reiterated an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Finally, Citigroup restated a “sell” rating on shares of Straumann in a research note on Thursday, July 9th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold”.

Straumann Stock Performance

The company has a 50 day moving average of $12.59 and a two-hundred day moving average of $11.71.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.